CL2007002053A1 - COMPOUNDS DERIVED FROM 3-AZABICICLO [3.1.0] HEXANO, VANYLOID RECEPTORS MEDIATORS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE TO PREVENT, IMPROVE OR TREAT DISEASES SUCH AS PAIN, MIGRANE, INF - Google Patents

COMPOUNDS DERIVED FROM 3-AZABICICLO [3.1.0] HEXANO, VANYLOID RECEPTORS MEDIATORS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE TO PREVENT, IMPROVE OR TREAT DISEASES SUCH AS PAIN, MIGRANE, INF

Info

Publication number
CL2007002053A1
CL2007002053A1 CL200702053A CL2007002053A CL2007002053A1 CL 2007002053 A1 CL2007002053 A1 CL 2007002053A1 CL 200702053 A CL200702053 A CL 200702053A CL 2007002053 A CL2007002053 A CL 2007002053A CL 2007002053 A1 CL2007002053 A1 CL 2007002053A1
Authority
CL
Chile
Prior art keywords
compounds
vanyloid
azabiciclo
migrane
hexano
Prior art date
Application number
CL200702053A
Other languages
Spanish (es)
Inventor
Atmaram Gharat Neeli Laxmikant
Original Assignee
Glenmark Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Sa filed Critical Glenmark Pharmaceuticals Sa
Publication of CL2007002053A1 publication Critical patent/CL2007002053A1/en

Links

CL200702053A 2006-07-17 2007-07-13 COMPOUNDS DERIVED FROM 3-AZABICICLO [3.1.0] HEXANO, VANYLOID RECEPTORS MEDIATORS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE TO PREVENT, IMPROVE OR TREAT DISEASES SUCH AS PAIN, MIGRANE, INF CL2007002053A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1136MU2006 2006-07-17
US83556006P 2006-08-03 2006-08-03
IN381MU2007 2007-02-27

Publications (1)

Publication Number Publication Date
CL2007002053A1 true CL2007002053A1 (en) 2008-06-06

Family

ID=40261419

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200702053A CL2007002053A1 (en) 2006-07-17 2007-07-13 COMPOUNDS DERIVED FROM 3-AZABICICLO [3.1.0] HEXANO, VANYLOID RECEPTORS MEDIATORS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE TO PREVENT, IMPROVE OR TREAT DISEASES SUCH AS PAIN, MIGRANE, INF

Country Status (2)

Country Link
CL (1) CL2007002053A1 (en)
TW (1) TW200813011A (en)

Also Published As

Publication number Publication date
TW200813011A (en) 2008-03-16

Similar Documents

Publication Publication Date Title
CL2007003832A1 (en) COMPOUNDS DERIVED FROM AZAESPIRO; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE TO PREVENT AND TREAT ANXIETY, DEPRESSIVE DISORDERS, AMONG OTHER DISEASES.
CL2007002708A1 (en) COMPOUNDS DERIVED FROM PIRROLO [2,3-B] PIRIDINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER, CAQUEXY, INFLAMMATORY DISORDERS, AMONG OTHERS.
CL2007001918A1 (en) SUBSTITUTED HETEROARILY DERIVATIVE COMPOUNDS; METHOD FOR THE PREPARATION OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, DEPRESSION, ALZHEIMER'S DISEASE AND HYPERTENSION BETWEEN OTHERS.
CL2008001921A1 (en) COMPOUNDS DERIVED FROM REPLACED HETEROCICLES; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS ICTUS, CEREBRAL ISCHEMIA, ALZHEIMER, PAIN, AMONG OTHERS.
CL2009000349A1 (en) Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
CL2007002610A1 (en) COMPOUNDS DERIVED FROM REPLACED BIPIRIDINE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND / OR PROFILAXIS OF DISEASES SUCH AS HYPERTONIA, DIABETES, MYOCARDIAL INFARTS, BETWEEN OTHERS.
CL2007002513A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED ISOINDOLIN, INTERMEDIATE COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND PREVENTION OF DISEASES SUCH AS CANCER, PAIN, MACULAR DEGENERATION, AMONG OTHERS.
CL2007002752A1 (en) COMPOUNDS DERIVED FROM 3- (4-OXO-4H-QUINAZOLIN-3-IL) -PIPERIDINA-2,6-DIONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT OR PREVENT DISEASES SUCH AS CANCER, PAIN, MACULAR DEGENERATION, PULMONARY DISORDER, TR
CL2007002169A1 (en) COMPOUNDS DERIVED FROM N- (AMINO-HETEROARIL) -1H-INDOL-2-CARBOXAMIDS; PREPARATION PROCEDURE; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND TO PREVENT OR TREAT INFLAMMATION, UROLOGICAL DISORDERS, GASTROINTESTINE
CL2007003440A1 (en) COMPOUNDS DERIVED FROM AZACICLOALCANOS, INHIBITORS FROM ESTEAROIL-COENZIMA TO DELTA-9 DESATURASA; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF DISEASES SUCH AS TYPE 2 DIABETES, INSULIN RESISTANCE, LIPID DISORDERS, OBESIDA
CL2011000144A1 (en) Compounds derived from benzo (1,4) dioxin-2-ylmethyl-sulfamide; pharmaceutical compositions containing them; process to prepare them and use in the treatment of anxiety, epilepsy, pain, substance abuse, related disorders, among others.
CL2007001882A1 (en) COMPOUNDS DERIVED FROM IMIDAZOPIRIMIDINE; PROCESS TO PREPARE THE COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE PREVENTION AND / OR TREATMENT OF COGNITIVE DISORDERS.
CL2007002099A1 (en) COMPOUNDS DERIVED FROM 3H-ESPIRO (1-BENZOFURAN-2,4'-PIPERIDINA); PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF RESPIRATORY DISEASES, SUCH AS COPD AND ASTHMA.
CL2013001295A1 (en) Compounds derived from 2,3-dihydromidazo (1,2-c) quinazoline substituted with amino alcohols; intermediate compound and its use; pharmaceutical composition; pharmaceutical combination; and its use to treat hyperproliferative disorders and diseases associated with angiogenesis.
WO2007038669A3 (en) Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
CL2004001267A1 (en) COMPOUNDS DERIVED FROM QUINAZOLINA, QUINASA INHIBITOR; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT CELLULAR PROLIFERATIVE DISORDERS SUCH AS ATEROSCLEROSIS,
CL2007003819A1 (en) COMPOUNDS DERIVED FROM ISOQUINOLIN AND ISOQUINOLINONA; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT AND / OR PREVENT HYPERTENSION, RETINOPATHY, GLAUCOMA, PULMONARY FIBROSIS, ALZHEIMER, AMONG OTHER DISEASES.
CL2008001493A1 (en) COMPOUND DERIVED FROM 3- (IMIDAZOLIL) -PIRAZOLO [3,4-B] PIRIDINE; PROCEDURE FOR PREPARING SUCH COMPOUND; AND ITS USE TO TREAT INFLAMMATION, IMMUNORREGULATORY DISORDERS, AMONG OTHERS.
CL2007001881A1 (en) COMPOUNDS DERIVED FROM IMIDAZOPIRIMIDINE; PROCESS TO PREPARE THE COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE PREVENTION AND / OR TREATMENT OF COGNITIVE DISORDERS.
CL2008000593A1 (en) USE OF COMPOUNDS DERIVED FROM REPLACED HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND OTHER ACTIVE AGENTS; AND ITS USE TO TREAT DIABETES, ATEROSCLEROTIC DISEASE OF ARTERIES BETWEEN OTHER DISEASES.
CL2011000544A1 (en) Compounds derived from benzamide n substituted by heterocycle, cannabinoid receptor ligands; pharmaceutical composition; and its use to treat pain, among other diseases.
CL2007002971A1 (en) COMPOUNDS DERIVED FROM AMINOMETIL-4-IMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND ITS USE TO TREAT DEPRESSION, ANXIETY, BIPOLAR DISORDER, AMONG OTHERS.
CL2007002919A1 (en) COMPOUNDS DERIVED FROM PIRIDO [2,3-B] INDOL, QUINASE INHIBITORS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT CANCER, AMONG OTHER DISEASES.
WO2006047032A3 (en) Indole compounds useful as serotonin selective agents
CL2013001459A1 (en) Compounds derived from quinazolincarboxamide azetidine; process to prepare them; pharmaceutical composition that includes them; set (kit); and its use for the treatment of hyperproliferative diseases such as cancer, inflammation, pancreatitis or kidney disease, pain, benign skin hyperplasia among others.